Improving Access to Genetic Testing for Unexplained Epilepsy
In a recent study, researchers looked at how well neurologists in the United States are following new guidelines for genetic testing and counseling for patients with unexplained epilepsy.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
In a recent study, researchers looked at how well neurologists in the United States are following new guidelines for genetic testing and counseling for patients with unexplained epilepsy.
This study looked at a specific gene called ADAM23 and its potential role in causing focal epilepsy, which is a type of seizure disorder.
This study looked at children with a specific genetic condition called SYNGAP1-related developmental and epileptic encephalopathy (DEE), which causes severe developmental issues and epilepsy.
Researchers studied the connection between enlarged perivascular spaces (ePVS) in the brain and certain markers of epilepsy in patients undergoing a specific type of brain monitoring called stereo-electroencephalography (SEEG).
This study looked at 37 children who had changes in a specific part of their DNA called the 15q11.2 region.
This study looked at a rare genetic disorder called spinocerebellar ataxia type 13 (SCAR13) in two families from Pakistan.
Researchers studied how often unreported information about genetic changes, known as variants of uncertain significance (VUS), is found in children with epilepsy.
Researchers studied the effects of gamma rhythm stimulation, specifically at 40 Hz, on cognitive function in people with Alzheimer’s disease (AD).
This study looked at four children who had mutations in a specific gene called BCKDK.